Home Olink

Olink

acquired
IPO
Developer of Biomolecular Analysis Technology
Basic
Enterprise Profile

Basic Information

Olink is a private company dedicated to developing groundbreaking biomolecular analysis technology. Olink provides unparalleled high-multiplexing technology for identifying actionable biomarkers, with a focus on the human plasma proteome. Using minimal sample volumes, they deliver quantifiable results with high throughput, exceptional sensitivity, and specificity, covering a wide dynamic range. The company's mission is to accelerate proteomics research in collaboration with the scientific community across multiple disease areas, enabling new discoveries and a better understanding of complex real-time human biology.
Olink Holding AB
Sweden
51~100 people
January 01, 2004
info@olink.com

Enterprise Profile

Industrial Sector
New Drug Development Information Technology Vendors Scientific Research and Experimental Development Services
Technology
Protein Technology
Concept
Health Management Disease Treatment
Application Scenarios
Biological Products